• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 739

Mannanase enzyme from Talaromyces leycettanus produced in Aspergillus niger

Intended Use: For use as a processing aid during instant coffee production at the minimum levels necessary to achieve the intended technical effect.
Basis: Scientific procedures
Notifier: Novozymes North America, Inc.
Notifier Address: 77 Perry Chapel Church Road, Box 576
Franklinton, NC 27525
GRAS Notice (releasable information): GRN 739 (in PDF) (622 kB)
Date of closure: Apr 25, 2018
FDA's Letter: FDA has no questions (in PDF) (113 KB)